nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

15.02.2020 | Original Article

The emergence of carbapenemase bla_NDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients

verfasst von: Mahmoud M. Tawfick, Walaa A. Alshareef, Hager A. Bendary, Hadir Elmahalawy, Abeer K. Abdulall

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Carbapenem resistance among Enterobacteriaceae is a major concern that is increasingly reported worldwide. The objective of this study is to determine the incidence of carbapenem resistance as well as to investigate for carbapenemase-encoding genes among Enterobacteriaceae clinical isolates from cancer patients at different cancer institutes in Egypt. This determination was a cross-sectional study with a total of 135 clinical isolates collected over a period of 1 year. All isolates were sub-cultured on ChromID agar and subjected to phenotypic and molecular detection of carbapenemases. Most of the Enterobacteriaceae isolates were MDR with high resistance rates against tested antimicrobials. Overall, the results of PCR assays revealed that 89.62% (121/135) of isolates harbored one or more of the carbapenemase-encoding genes, while phenotypic assays revealed the production of carbapenemases in 68.88% (93/135) of isolates. BlastN analysis against the non-redundant genome sequences available in the GenBank database revealed that the bla_NDM-1 gene was the most prevalent genotype of carbapenemases in 93/135 (68.88%), followed by bla_OXA-48 44/135 (32.59%), bla_OXA-23 42/135 (31.11%), and bla_KPC-2 2/135 (1.48%). Klebsiella pneumoniae isolates harbored the highest number of carbapenemase-encoding genes 34/121 (28.09%). The high prevalence of carbapenemases and/or their encoding genes among MDR Enterobacteriaceae bacteria in Egypt is alarming, thus, the management of serious infections caused by Enterobacteriaceae, particularly in cancer patients will be challenging to clinicians. Carbapenemase bla_NDM genotype is emerging in cancer healthcare settings in Egypt, which could be the cause of the current increase in carbapenemase-producing Enterobacteriaceae.

Nordmann P, Dortet L, Poirel L (2012) Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 18:263–272. https://doi.org/10.1016/j.molmed.2012.03.003 CrossRefPubMed

Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798. https://doi.org/10.3201/eid1710.110655 CrossRefPubMedPubMedCentral

Paterson DL (2006) Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34:S20–S28. https://doi.org/10.1016/j.ajic.2006.05.238 CrossRefPubMed

Ghaith DM, Zafer MM, Said HM, Elanwary S, Elsaban S, Al-Agamy MH et al (2019) Genetic diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-019-03761-2

Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F (2014) Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. Biomed Res Int 2014:303104. https://doi.org/10.1155/2014/303104 CrossRefPubMedPubMedCentral

Moquet O, Bouchiat C, Kinana A, Seck A, Arouna O, Bercion R et al (2011) Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerg Infect Dis 17:143–144. https://doi.org/10.3201/eid1701.100244 CrossRefPubMedPubMedCentral

Karuniawati A, Saharman YR, Lestari DC (2013) Detection of carbapenemase encoding genes in Enterobacteriace, Pseudomonas aeruginosa, and Acinetobacter baumanii isolated from patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones 45:101–106. https://www.ncbi.nlm.nih.gov/pubmed/23770789. Accessed Apr 2013

Abdulall AK, Tawfick MM, El Manakhly AR, El Kholy A (2018) Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt. Eur J Clin Microbiol Infect Dis 37:1647–1652. https://doi.org/10.1007/s10096-018-3294-7 CrossRefPubMed

Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M et al (2005) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. Arch Intern Med 165:1430. https://doi.org/10.1001/archinte.165.12.1430 CrossRefPubMed

10.

Queenan AM, Bush K (2007) Carbapenemases: the versatile-lactamases. Clin Microbiol Rev 20:440–458. https://doi.org/10.1128/CMR.00001-07 CrossRefPubMedPubMedCentral

11.

Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M et al (2010) Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16:112–122. https://doi.org/10.1111/j.1469-0691.2009.03116.x CrossRefPubMed

12.

Huang T-D, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y (2014) Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother 69:445–450. https://doi.org/10.1093/jac/dkt367 CrossRefPubMed

13.

Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V et al (2012) Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18:432–438. https://doi.org/10.1111/j.1469-0691.2012.03815.x CrossRefPubMed

14.

The Clinical and Laboratory Standards Institute (2016) Performance Standards for Antimicrobial Susceptibility Testing CLSI supplement M100S

15.

Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A (2009) Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 47:1631–1639. https://doi.org/10.1128/JCM.00130-09 CrossRefPubMedPubMedCentral

16.

Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S (2008) First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 62:1257–1260. https://doi.org/10.1093/jac/dkn364 CrossRefPubMed

17.

Kaore N, Nagdeo N, Thombare V (2012) Phenotypic methods for detection of various β-lactamases in Gram-negative clinical isolates: need of the hour. Chronicles Young Sci 3:292. https://doi.org/10.4103/2229-5186.103098 CrossRef

18.

Pournaras S, Poulou A, Tsakris A (2010) Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 65:1319–1321. https://doi.org/10.1093/jac/dkq124 CrossRefPubMed

19.

Bakthavatchalam YD, Veeraraghavan B, Peter JV, Rajinikanth J, Inbanathan FY, Devanga Ragupathi NK et al (2016) Novel Observations in 11 heteroresistant vancomycin-intermediate methicillin-resistant Staphylococcus aureus strains from South India. Genome Announc 4. https://doi.org/10.1128/genomeA.01425-16

20.

Kabir MI, Rahman MB, Smith W, Lusha MAF, Azim S, Milton AH (2016) Knowledge and perception about climate change and human health: findings from a baseline survey among vulnerable communities in Bangladesh. BMC Public Health 16:266. https://doi.org/10.1186/s12889-016-2930-3 CrossRefPubMedPubMedCentral

21.

Maurer A, Draba V, Jiang Y, Schnaithmann F, Sharma R, Schumann E et al (2015) Modelling the genetic architecture of flowering time control in barley through nested association mapping. BMC Genomics 16:290. https://doi.org/10.1186/s12864-015-1459-7 CrossRefPubMedPubMedCentral

22.

Pitout JDD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873–5884. https://doi.org/10.1128/AAC.01019-15 CrossRefPubMedPubMedCentral

23.

Hrabák J, Chudáčkova E, Papagiannitsis CC (2014) Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin Microbiol Infect 20:839–853. https://doi.org/10.1111/1469-0691.12678 CrossRefPubMed

24.

Huang M, Parker MJ, Stubbe J (2014) Choosing the right metal: case studies of class I ribonucleotide reductases. J Biol Chem 289:28104–28111. https://doi.org/10.1074/jbc.R114.596684 CrossRefPubMedPubMedCentral

25.

van der Zee HH, Jemec GBE (2015) New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes. J Am Acad Dermatol 73:S23–S26. https://www.ncbi.nlm.nih.gov/pubmed/26950458. Accessed Feb 2016

26.

Maulana F, Ayalew H, Anderson JD, Kumssa TT, Huang W, Ma X-F (2018) Genome-wide association mapping of seedling heat tolerance in winter wheat. Front Plant Sci 9:1272. https://doi.org/10.3389/fpls.2018.01272 CrossRefPubMedPubMedCentral

27.

Liao Q, Xie Y, Wang C, Zong Z, Wu S, Liu Y et al (2019) Development and evaluation of the method for detecting metallo-carbapenemases among carbapenemase-producing Enterobacteriaceae. J Microbiol Methods 163:105652. https://doi.org/10.1016/J.MIMET.2019.105652 CrossRefPubMed

28.

Abd El-Hamid MI, Bendary MM, Merwad AMA, Elsohaby I, Mohammad Ghaith D, Alshareef WA (2019) What is behind phylogenetic analysis of hospital-, community- and livestock-associated methicillin-resistant Staphylococcus aureus? Transbound Emerg Dis:tbed.13170. https://doi.org/10.1111/tbed.13170

29.

Bendary MM, Solyman SM, Azab MM, Mahmoud NF, Hanora AM (2016) Characterization of methicillin resistant Staphylococcus aureus isolated from human and animal samples in Egypt. Cell Mol Biol (Noisy-le-grand) 62:94–100. http://www.ncbi.nlm.nih.gov/pubmed/26950458

30.

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT et al (2017) Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 17:153–163. https://doi.org/10.1016/S1473-3099(16)30257-2 CrossRefPubMed

31.

World Health Organization (2014) Health service coverage. In: World health statistics 2014. WHO Press, Geneva, pp 104–115

32.

Kádár B, Kocsis B, Tóth Á, Damjanova I, Szász M, Kristóf K et al (2013) Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae. Acta Microbiol Immunol Hung 60:201–209. https://doi.org/10.1556/AMicr.60.2013.2.10 CrossRefPubMed

33.

Baran I, Aksu N (2016) Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob 15:20. https://doi.org/10.1186/s12941-016-0136-2 CrossRefPubMedPubMedCentral

34.

Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G et al (2018) Hypervirulent Klebsiella pneumoniae in cryptogenic liver abscesses, Paris, France. Emerg Infect Dis 24:221–229. https://doi.org/10.3201/eid2402.170957 CrossRefPubMedPubMedCentral

35.

Oduyebo O, Falayi O, Oshun P, Ettu A (2015) Phenotypic determination of carbapenemase producing Enterobacteriaceae isolates from clinical specimens at a tertiary hospital in Lagos, Nigeria. Niger Postgrad Med J 22:223. https://doi.org/10.4103/1117-1936.173973 CrossRefPubMed

36.

Rudresh SM, Ravi GS, Sunitha L, Hajira SN, Kalaiarasan E, Harish BN (2017) Simple, rapid, and cost-effective modified Carba NP test for carbapenemase detection among Gram-negative bacteria. J Lab Physicians 9:303–307. https://doi.org/10.4103/JLP.JLP_138_16 CrossRefPubMedPubMedCentral

37.

AlTamimi M, AlSalamah A, AlKhulaifi M, AlAjlan H (2017) Comparison of phenotypic and PCR methods for detection of carbapenemases production by Enterobacteriaceae. Saudi J Biol Sci 24:155–161. https://doi.org/10.1016/j.sjbs.2016.07.004 CrossRefPubMed

38.

Solanki R, Vanjari L, Subramanian S, Aparna B, Nagapriyanka E, Lakshmi V (2014) Comparative evaluation of multiplex PCR and routine laboratory phenotypic methods for detection of carbapenemases among gram negative Bacilli. J Clin Diagn Res 8:DC23–DC26. https://doi.org/10.7860/JCDR/2014/10794.5322 CrossRefPubMedPubMedCentral

39.

Kumar S, Mehra SK. Performance of modified Hodge test and combined disc test for detection of carbapenemases in clinical isolates of Enterobacteriaceae. Int J Curr Microbiol App Sci 2015;4:255–261. doi: https://www.ijcmas.com/vol-4-5/SanjeevKumarandS.K.Mehra.pdf

40.

Kazi M, Drego L, Nikam C, Ajbani K, Soman R, Shetty A et al (2015) Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis 34:467–472. https://doi.org/10.1007/s10096-014-2249-x CrossRefPubMed

41.

El-Sweify MA, Gomaa NI, El-maraghy NN (2015) Phenotypic detection of carbapenem resistance among Klebsiella pneumoniae in Suez Canal University Hospitals, Ismailiya, Egypt. Int J Curr Microbiol App Sci 4:10–18

42.

Studentova V, Papagiannitsis CC, Izdebski R, Pfeifer Y, Chudackova E, Bergerova T et al (2015) Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers. Folia Microbiol (Praha) 60:119–129. https://doi.org/10.1007/s12223-014-0349-8 CrossRef

43.

Devi U, Bora R, Das J, Mahanta J (2018) Extended-spectrum β-lactamase, carbapenemase-producing Gram-negative bacilli in neonates from a tertiary care centre in Dibrugarh, Assam. India Indian J Med Res 147:110. https://doi.org/10.4103/ijmr.IJMR_1288_16 CrossRefPubMed

44.

Khosravi Y, Loke MF, Chua EG, Tay ST, Vadivelu J (2012) Phenotypic detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa. Sci World J 2012:1–7. https://doi.org/10.1100/2012/654939 CrossRef

45.

Poirel L, Revathi G, Bernabeu S, Nordmann P (2011) Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 55:934–936. https://doi.org/10.1128/AAC.01247-10 CrossRefPubMed

46.

Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA, Poirel L et al (2012) Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol 50:525–527. https://doi.org/10.1128/JCM.05956-11 CrossRefPubMedPubMedCentral

47.

Coetzee J, Brink A (2011) The emergence of carbapenem resistance in Enterobacteriaceae in South Africa. South African J Epidemiol Infect 26:239–240. https://doi.org/10.1080/10158782.2011.11441460 CrossRef

48.

Iman FEG, Marwa AM, Doaa AY (2016) Phenotypic and genotypic methods for detection of metallo beta lactamases among carbapenem resistant Enterobacteriaceae clinical isolates in Alexandria Main University Hospital. Afr J Microbiol Res 10:32–40. https://doi.org/10.5897/AJMR2015.7821 CrossRef

49.

Lutgring JD, Zhu W, de Man TJB, Avillan JJ, Anderson KF, Lonsway DR et al (2018) Phenotypic and genotypic characterization of Enterobacteriaceae producing oxacillinase-48-like carbapenemases. United States Emerg Infect Dis 24:700–709. https://doi.org/10.3201/eid2404.171377 CrossRefPubMed

50.

Lloyd NA, Nazaret S, Barkay T (2018) Whole genome sequences to assess the link between antibiotic and metal resistance in three coastal marine bacteria isolated from the mummichog gastrointestinal tract. Mar Pollut Bull 135:514–520. https://doi.org/10.1016/J.MARPOLBUL.2018.07.051 CrossRefPubMed

51.

Hamprecht A, Vehreschild JJ, Seifert H, Saleh A (2018) Rapid detection of NDM, KPC and OXA-48 carbapenemases directly from positive blood cultures using a new multiplex immunochromatographic assay. PLoS One 13:e0204157. https://doi.org/10.1371/journal.pone.0204157 CrossRefPubMedPubMedCentral

52.

Vali L, Dashti AA, Jadaon MM, El-Shazly S (2015) The emergence of plasmid mediated quinolone resistance qnrA2 in extended spectrum β-lactamase producing Klebsiella pneumoniae in the Middle East. Daru 23:34. https://doi.org/10.1186/s40199-015-0116-7 CrossRefPubMedPubMedCentral

Titel: The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients
verfasst von: Mahmoud M. Tawfick
Walaa A. Alshareef
Hager A. Bendary
Hadir Elmahalawy
Abeer K. Abdulall
Publikationsdatum: 15.02.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2020
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03839-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The emergence of carbapenemase bla_NDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Influenza and antiviral resistance: an overview

The increased recurrence rate of liver abscess caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae

Blood cultures of adult patients discharged from the emergency department—is the safety net reliable?

Prevalence of respiratory viruses and antiviral MxA responses in children with febrile urinary tract infection

Group a streptococcal bacteremias in Southwest Finland 2007–2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection

Antibiotic use and resistance: a nationwide questionnaire survey among French dentists

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin